Data from the tumor-bearing nude mice model suggested that treatments of AMPK activator, angustoline, and (AMPK activator + angustoline) inhibited the growth and development of KYSE450 tumors implanted in nude mice. The gene discussed is PRKAA2; the disease is neoplasm.